Pegavision Corporation Stock

Equities

6491

TW0006491004

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 06:00:00 2024-07-01 pm EDT 5-day change 1st Jan Change
496.5 TWD +2.58% Intraday chart for Pegavision Corporation +2.37% +25.22%
Sales 2024 * 7.64B 234M Sales 2025 * 8.77B 269M Capitalization 38.73B 1.19B
Net income 2024 * 2.17B 66.36M Net income 2025 * 2.56B 78.27M EV / Sales 2024 * 4.22 x
Net cash position 2024 * 6.5B 199M Net cash position 2025 * 8.51B 261M EV / Sales 2025 * 3.44 x
P/E ratio 2024 *
17.9 x
P/E ratio 2025 *
15.1 x
Employees -
Yield 2024 *
2.54%
Yield 2025 *
2.76%
Free-Float 50.57%
More Fundamentals * Assessed data
Dynamic Chart
Pegavision Corporation Announces Cash Dividends Payable on July 10, 2024 CI
Pegavision Corporation Approves Director Appointments CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pegavision Corporation announced that it expects to receive TWD 0.08 million in funding CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup DJ
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Pegavision Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pegavision Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pegavision Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
1 day+2.58%
1 week+2.37%
Current month+3.65%
1 month+5.08%
3 months+2.27%
6 months+24.28%
Current year+25.22%
More quotes
1 week
476.00
Extreme 476
502.00
1 month
459.00
Extreme 459
502.00
Current year
368.00
Extreme 368
548.00
1 year
328.00
Extreme 328
548.00
3 years
270.50
Extreme 270.5
611.00
5 years
81.50
Extreme 81.5
678.00
10 years
63.71
Extreme 63.71
678.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-06-13
Director of Finance/CFO - 13-12-26
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 63 09-08-11
Chief Executive Officer - 18-06-13
Chairman - 09-08-11
More insiders
Date Price Change Volume
24-07-02 496.5 +2.58% 1,062,354
24-07-01 484 +1.04% 521,325
24-06-28 479 -0.10% 517,322
24-06-27 479.5 -0.62% 618,390
24-06-26 482.5 -0.52% 652,050

End-of-day quote Taiwan S.E., July 01, 2024

More quotes
Pegavision Corp is primarily engaged in the manufacture and sale of private brand contact lenses, as well as the original equipment manufacturing (OEM) business. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
496.5 TWD
Average target price
546.8 TWD
Spread / Average Target
+10.13%
Consensus